Found: 12
Select item for more details and to access through your institution.
Pemphigus Disease and Area Index: Unmet needs in the real‐world management of pemphigus.
- Published in:
- Oral Diseases, 2024, v. 30, n. 4, p. 2275, doi. 10.1111/odi.14713
- By:
- Publication type:
- Article
Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/7399468
- By:
- Publication type:
- Article
Factors associated with the healing time of pemphigus vulgaris oral lesions: A prospective study.
- Published in:
- Oral Diseases, 2023, v. 29, n. 5, p. 2248, doi. 10.1111/odi.14236
- By:
- Publication type:
- Article
Nail abnormalities in subepidermal blistering diseases: a cross‐sectional study.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 6, p. 783, doi. 10.1111/ijd.16624
- By:
- Publication type:
- Article
Adverse outcome and severity of COVID‐19 in patients with autoimmune bullous diseases: A historical cohort study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 9, p. 1, doi. 10.1111/dth.15672
- By:
- Publication type:
- Article
Lichen planopilaris: histopathological survey of 70 vertical sections of scalp biopsies.
- Published in:
- Iranian Journal of Dermatology, 2022, v. 25, n. 1, p. 24, doi. 10.22034/ijd.2021.267246.1304
- By:
- Publication type:
- Article
Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 1, p. e14, doi. 10.1111/ijd.15706
- By:
- Publication type:
- Article
Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 5, p. 1, doi. 10.1111/dth.15075
- By:
- Publication type:
- Article
Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Journal of Cosmetic Dermatology, 2021, v. 20, n. 8, p. 2498, doi. 10.1111/jocd.13867
- By:
- Publication type:
- Article
Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 1, p. 1, doi. 10.1111/dth.14633
- By:
- Publication type:
- Article
Treatment of pemphigus patients in the COVID‐19 era: A specific focus on rituximab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14188
- By:
- Publication type:
- Article
Investigating expression pattern of eight immune‐related genes in pemphigus patients compared with the healthy controls and after rituximab therapy: Potential roles of CTLA4 and FCGR3A genes expression in outcomes of rituximab therapy.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14380
- By:
- Publication type:
- Article